Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akhtar Ashfaq

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Kidney360|August 26, 2025
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?Charles W Bishop, Akhtar Ashfaq, John Choe, et al.
American Journal of Nephrology|March 2, 2019
Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical ParametersNicholas S Roetker, Yi Peng, Akhtar Ashfaq, et al.
Nephron|April 24, 2024
Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary HyperparathyroidismDomenico Merante, Henrik Schou, Isabelle Morin, et al.
BMC Nephrology|August 8, 2025
High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case reportAkhtar Ashfaq, John Choe, Samir Tabash, et al.
Journal of Nephrology|May 21, 2004
Recurrent membranous nephropathy and leiomyosarcoma in the renal allograft of a lupus patientAkhtar Ashfaq, J Ezra Haller, Robert Mossey, et al.
BMC Nephrology|March 8, 2019
Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in EnglandLaura Horne, Akhtar Ashfaq, Sharon MacLachlan, et al.
Plos One|March 29, 2023
Factors in nephrologists' decision to treat pre-dialysis CKD patients with vitamin D insufficiency and SHPT: A discrete choice experimentAnand C Reddy, Andy Nguyen, November H McGarvey, et al.
American Journal of Nephrology|November 24, 2021
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release CalcifediolGeorge Fadda, Michael J Germain, Varshasb Broumand, et al.
American Journal of Nephrology|August 27, 2024
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism PatientsCharles W Bishop, Akhtar Ashfaq, Stephen A Strugnell, et al.
American Journal of Nephrology|June 4, 2025
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical TrialCharles W Bishop, Akhtar Ashfaq, John Choe, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Kidney360|August 26, 2025
Managing Dysregulated Vitamin D Metabolism in CKD: Time to Update Conventional Wisdom?Charles W Bishop, Akhtar Ashfaq, John Choe, et al.
American Journal of Nephrology|March 2, 2019
Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical ParametersNicholas S Roetker, Yi Peng, Akhtar Ashfaq, et al.
Nephron|April 24, 2024
Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary HyperparathyroidismDomenico Merante, Henrik Schou, Isabelle Morin, et al.
BMC Nephrology|August 8, 2025
High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case reportAkhtar Ashfaq, John Choe, Samir Tabash, et al.
Journal of Nephrology|May 21, 2004
Recurrent membranous nephropathy and leiomyosarcoma in the renal allograft of a lupus patientAkhtar Ashfaq, J Ezra Haller, Robert Mossey, et al.
BMC Nephrology|March 8, 2019
Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in EnglandLaura Horne, Akhtar Ashfaq, Sharon MacLachlan, et al.
Plos One|March 29, 2023
Factors in nephrologists' decision to treat pre-dialysis CKD patients with vitamin D insufficiency and SHPT: A discrete choice experimentAnand C Reddy, Andy Nguyen, November H McGarvey, et al.
American Journal of Nephrology|November 24, 2021
Real-World Assessment: Clinical Effectiveness and Safety of Extended-Release CalcifediolGeorge Fadda, Michael J Germain, Varshasb Broumand, et al.
American Journal of Nephrology|August 27, 2024
Sustained Reduction of Elevated Intact Parathyroid Hormone Concentrations with Extended-Release Calcifediol Slows Chronic Kidney Disease Progression in Secondary Hyperparathyroidism PatientsCharles W Bishop, Akhtar Ashfaq, Stephen A Strugnell, et al.
American Journal of Nephrology|June 4, 2025
Extended-Release Calcifediol Normalized 1,25-Dihydroxyvitamin D and Prevented Progression of Secondary Hyperparathyroidism in Hemodialysis Patients in a Pilot Randomized Clinical TrialCharles W Bishop, Akhtar Ashfaq, John Choe, et al.
Pageof 3